General Information
|
|
Product
|
IL23 P19 Peptide
|
Description
|
Antigenic Blocking Peptide Interleukin-23 subunit alpha Antibody C-epitope
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
Peptide Description
|
Synthetic peptide corresponding to C terminal region amino acids 162-179 of Human IL23 P19. Peptide was covalently modified.
Sequence:
FKILRSLQAFAAVAARV
|
Accession #
|
NCBI: NP_057668.1
|
Physical Properties
|
|
Quantity
|
250 µg
|
Volume
|
100 µl
|
Form
|
Antigenic Blocking Peptide
|
Determinant
|
C-epitope
|
Storage
|
-20⁰C for long term storage
|
Application Protocol
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
Protein
|
Uniprot #
|
Q9NPF7
|
Overview
|
a heterodimeric cytokine which functions in innate and adaptive immunity;stimulates memory rather than naive T-cells and promotes production of proinflammatory cytokines;IL-23 induces autoimmune inflammation
|
Molecular Function
|
Cytokine
|
Subcellular Location
|
Secreted
|
Expression
|
Secreted by activated dendritic and phagocytic cells and keratinocytes. Also expressed by dermal Langerhans cells (at protein level)
|
Structure
|
Heterodimer
|
Alternative Nomenclature
|
alpha subunit P19 antibody
IL-23 subunit alpha antibody
IL-23-A antibody
IL-23p19 antibody
IL23 antibody
interleukin 23 alpha subunit p19 antibody
JKA3 induced upon T cell activation antibody
MGC79388 antibody
P19 antibody
SGRF antibody
|
|
|